Summary
The effect of different doses of 5.6-dihydroxytryptamine—a serotonin analogue which produces a degeneration of serotonin containing nerve terminals in the rat brain—on the noradrenaline (NA) content and—storage sites of peripheral sympathetic nerves in the mouse and rat heart, spleen, rectum and vas deferens has been investigated by fluorescence—, electron microscopical and chemical methods. Moderate doses of 5.6-dihydroxytryptamine (5.6-DHT) (10–45 mg/kg ip.) cause a temporary, reversible displacement of noradrenaline from the adrenergic nerves concomitant with a significant increase in the number and opacity of small and especially large granular vesicles. The recovery of the neuronal NA concentration is, however, retarded after doses higher than 45 mg/kg (60 or 100 mg/kg ip.); a partial degeneration of varicose NA terminals is verified fluorescence- and electron microscopically. A combined treatment of animals with tyrosine hydroxylase inhibitors (α-methyl-paratyrosine or α-propyl-dopacetamide) and 5.6-DHT, in some instances also followed by reserpine, potentiates the destructive properties of 5.6-DHT; a similar potentiation is accomplished by reserpine posttreatment or by an additional pretreatment of animals with reserpine and nialamide.
The results suggest that 5.6-DHT when given in moderate doses (up to 45 mg/kg) may be handled by sympathetic adrenergic nerves like a false neurotransmitter which displaces noradrenaline from the stores, but that it causes a “chemical degeneration” of noradrenaline containing nerve terminals when applied either in single high doses (60 or 100 mg/kg ip.), or when administered in moderate non-degenerative doses together with drugs that impair the neuronal inactivation mechanisms for 5.6-DHT (granular uptake and storage mechanism and/or monoamine oxidase activity) and thus provoke a temporary increase in the amount of free 5.6-DHT in the neuron's cytoplasm.
The molar efficiency of 5.6-DHT in causing a chemical sympathectomy is clearly inferior to that caused by 6-hydroxydopamine. The differences are probably mainly due to differences in the affinity of both drugs to the amine uptake system located at the cell membrane and the membrane of the intraneuronal storage vesicles of the adrenergic nerve terminals.
Similar content being viewed by others
References
Baumgarten, H. G.: Vorkommen und Verteilung adrenerger Nervenfasern im Darm der Schleie (Tinca vulgaris Cuv.). Z. Zellforsch. 76, 248–259 (1967).
Baumgarten, H. G.: Uptake and distribution of false transmitters and their precursors in adrenergic sympathetic nerves of the guinea-pig vas deferens. In: Morphological aspects of andrology, eds. Holstein, A. F., Horstmann, E., p. 141–146. Fortschr. Androl., vol. I. Berlin: Grosse 1970.
Baumgarten, H. G.: Biogenic monoamines in the cyclostome and lower vertebrate brain. Progr. Histochem. Cytochem. 4, no. 1, 1971.
Baumgarten, H. G.: Wirkung von 5,6-Dihydroxytryptamin auf sympathisch adrenerge und zentralnervöse monoaminspeichernde Neurone bei der Ratte. Zbl. ges. Neurol. Psychiat. 1971, in press.
Baumgarten, H. G., Björklund, A., Holstein, A. F., Nobin, A.: Organization and ultrastructural identification of the catecholamine nerve terminals in the neural lobe and pars intermedia of the rat pituitary. Z. Zellforsch. 126, 483–517 (1972).
Baumgarten, H. G., Björklund, A., Lachenmayer, L., Nobin, A., Stenevi, U.: Long-lasting, selective depletion of brain serotonin by 5.6-dihydroxytryptamine. Acta physiol. scand. Suppl. 373 (1971).
Baumgarten, H. G., Evetts, K. D., Holman, R. B., Iversen, L. L., Vogt, M., Wilson, G.: Effect of 5.6-dihydroxytryptamine on monoaminerigic neurons in the central nervous system of the rat. J. Neurochem. 1972, in press.
Baumgarten, H. G., Holstein, A. F., Owman, Ch.: Auerbach's plexus of mammals and man: Electron microscopic identification of three different types of neuronal processes in myenteric ganglia of the large intestine from rhesus monkeys, guinea-pigs and man. Z. Zellforsch. 106, 376–397 (1970).
Baumgarten, H. G., Holstein, A. F., Rosengren, E.: Arrangement, ultrastructure and adrenergic innervation of smooth muscle layers of the ductuli efferentes, ductus epididymidis and ductus deferens in man. Z. Zellforsch. 120, 37–39 (1971).
Baumgarten, H. G., Lachenmayer, L.: Chemically induced degeneration of indoleamine containing nerve terminals in rat brain. Brain Res. 38, 1972, in press.
Baumgarten, H. G., Lachenmayer, L., Schlossberger, H. G.: Evidence for a degeneration of indoleamine containing nerve terminals in rat brain, induced by 5.6-dihydroxy-tryptamine. Z. Zellforsch. 125, 553–569 (1972).
Baumgarten, H. G., Wartenberg, H.: Time course of effects of 6-hydroxydopamine on sympathetic nerves and parenchymal cells of the lizard's pineal organ (Lacerta viridis). In preparation.
Bell, L. J., Iversen, L., Uretsky, N. J.: Time course of effects of 6-hydroxydopamine on catecholamine containing neurons in rat hypothalamus and striatum. Brit. J. Pharmacol. 40, 790–799 (1970).
Bennett, T., Burnstock, G., Cobb, J. L. S., Malmfors, T.: An ultrastructural and histochemical study of the short term effects of 6-hydroxydopamine on adrenergic nerves in the domestic fowl. Brit. J. Pharmacol. 38, 802–809 (1970).
Bertler, A., Carlsson, A., Rosengren, E.: A method for the fluorimetric determination of adrenaline and noradrenaline in tissues. Acta physiol. scand. 44, 273–292 (1958).
Bertler, A., Carlsson, A., Rosengren, E., Waldeck, B.: A method for the fluorimetric determination of adrenaline, noradrenaline and dopamine in tissues. Kgl. fysogr. Sällsk. Lund. Förh. 28, 121–123 (1958).
Breese, G. R., Traylor, T. D.: Effect of 6-hydroxydopamine on brain norepinephrine and dopamine: Evidence for selective degeneration of catecholamine neurons. J. Pharmacol. exp. Ther. 174, 413–420 (1970).
Champlain, J. de: Degeneration and regrowth of adrenergic nerve fibres in the rat peripheral tissues after 6-hydroxydopamine. Canad. J. Physiol. Pharmacol. 49, 345–355 (1971).
Falck, B., Owman, Ch.: A detailed methodological description of the fluorescence method for the cellular demonstration of biogenic monoamines. Acta Univ. Lund., Sectio II, No 7, 1–23 (1965).
Fillion, G. M. B., Lluch, S., Uvnäs, B.: Release of noradrenaline from the dog heart in situ after intravenous and intracoronary administration of 5-hydroxytryptamine. Acta physiol. scand. 83, 115–123 (1971).
Fozard, J. R., Clarke, D. E.: Restoration of blood pressure and heart rate responses to tyramine by infusion of 5-hydroxytryptamine in reserpine-treated pithed rats. J. Pharm. Pharmacol. 22, 862–864 (1970).
Furness, J. B., Campbell, G. R., Gillard, S. M., Malmfors, T., Cobb, J. L. S., Burnstock, G.: Cellular studies of sympathetic denervation produced by 6-hydroxydopamine in the vas deferens. J. Pharmacol. exp. Ther. 174, 111–122 (1970).
Fuxe, K., Ungerstedt, U.: Histochemical studies on the distribution of catecholamines and 5-hydroxytryptamine after intraventricular injection. Histochemie 13, 16–28 (1968).
Gillard, S. M., Read, J.: Fluorescence histochemical studies on the effects of 6-hydroxydopamine on adrenaline containing nerves in the toad. Z. Zellforsch. 118, 493–511 (1971).
Häggendal, J.: An improved method for the fluorimetric determination of small amounts of adrenaline and noradrenaline in plasma and tissues. Acta physiol. scand. 59, 242–254 (1963).
Haeusler, G., Haefely, W., Thoenen, H.: Chemical sympathectomy of the cat with 6-hydroxydopamine. J. Pharmacol. exp. Ther. 170, 50–61 (1969).
Iversen, L. L., Uretsky, N. J.: Regional effects of 6-hydroxydopamine on catecholamine containing neurones in rat brain and spinal cord. Brain. Res. 24, 364–367 (1970).
Jonsson, G., Sachs, Ch.: Effects of 6-hydroxydopamine on the uptake and storage of noradrenaline in sympathetic adrenergic neurons. Europ. J. Pharmacol. 9, 141–155 (1970).
Saner, A., Thoenen, H.: Contribution to the molecular mechanism of action of 6-hydroxydopamine. In: 6-Hydroxydopamine and catecholamine neurons, eds. Malmfors, T., Thoenen, H., p. 265–275. Amsterdam-London: North Holland Publ. Co. 1971.
Siggins, G. R., Bloom, F. E.: Cytochemical and physiological effects of 6-hydroxydopamine on periarteriolar nerves of frogs. Circulat. Res. 27, 23–38 (1970).
Sjöstrand, N. O., Swedin, G.: Effect of reserpine on the noradrenaline content of the vas deferens and seminal vesicle compared with the submaxillary gland and the heart of the rat. Acta physiol. scand. 72, 370–377 (1968).
Thoenen, H.: Biochemical alterations induced by 6-hydroxydopamine in peripheral adrenergic neurons. In: 6-Hydroxydopamine and catecholamine neurons, eds. Malmfors, T., Thoenen, H., p. 75–85. Amsterdam-London: North Holland Publ. Co. 1971.
Tranzer, J. P., Thoenen, H.: An electron microscopic study of selective acute degeneration of sympathetic nerve terminals after administration of 6-hydroxydopamine. Experientia (Basel) 24, 155–156 (1968).
Uretsky, N. J., Iversen, L. L.: Effects of 6-hydroxydopamine on catecholamine containing neurons in the rat brain. J. Neurochem. 17, 269–278 (1970).
Wagner, K.: Uncoupling of oxidative phosphorylation by 6-hydroxydopamine. In: 6-Hydroxydopamine and catecholamine neurons, eds. Malmfors, T., Thoenen, H., p. 277–278. Amsterdam-London: North Holland Publ. Co. 1971.
Wartenberg, H., Baumgarten, H. G.: Elektronenmikroskopische Untersuchungen zur Frage der photosensorischen und sekretorischen Funktion des Pinealorgans von Lacerta viridis und Lacerta muralis. Z. Anat. Entwickl.-Gesch. 127, 99–120 (1968).
Wartenberg, H., Baumgarten, H. G.: Untersuchungen zur fluoreszenz- und elektronenmikroskopischen Darstellung von 5-Hydroxytryptamin (5-HT) im Pinealorgan von Lacerta viridis und L. muralis. Z. Anat. Entwickl.-Gesch. 128, 185–210 (1969).
Author information
Authors and Affiliations
Additional information
Supported by grants from the Deutsche Forschungsgemeinschaft.
Rights and permissions
About this article
Cite this article
Baumgarten, H.G., Göthert, M., Holstein, A.F. et al. Chemical sympathectomy induced by 5.6-dihydroxytryptamine. Z.Zellforsch 128, 115–134 (1972). https://doi.org/10.1007/BF00306892
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00306892